Related Experiment Video
Updated: Jun 27, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
A health plan's integration of molecular diagnostics and the impact on treatment pathways for quality care
1Pharmacy Management, CareFirst BlueCross BlueShield, Baltimore, USA.
Abstract:
This Mid-Atlantic area Blues plan views genetic biomarkers as an important advancement in predicting recurrence rates and response to chemotherapy in estrogen-receptor-positive, node-negative, HER2-negative women with early-stage breast cancer. Care-First's Pay for Quality oncology program strives to combine clinically sound treatment with stable outcomes and predictable costs.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacogenomics: Identification of New Drug Targets
Modern Molecular Taxonomy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
